Ventricle Health

The mortality from #heartfailure remains high. A recent HFStats report from Heart Failure Society of America states "Without guideline-directed medical therapy (GDMT), the 2-year mortality rate of patients with HFrEF is estimated at 35%. " It's estimated that optimizing #GDMT in all eligible patients could prevent approximately 1.19 million deaths worldwide each year 🔥 This is not an unfixable problem. We are turning these numbers around one patient at a time. Join us! #HFequity #GDMTworks #Numbersdontlie Dan Bensimhon Anita Kelkar MD, MPH Greg Egnaczyk Sean O'Donnell Jason Kemmer Nissa Felton BSN, RN, PCCN, CHFN Rebecca Steele, MSN, RN, CNL Tara Beaird, RN, CHFN Shandy Guharoy

Nearly 2/3 of all HF hospitalizations occur because our patients' oral diuretics fail to decongest them adequately due to diuretic resistance. As a result, they require admission for IV diuretics as their only additional therapy. Intranasal bumetanide is a new formulation of a commonly-used loop diuretic (Bumex) that has been developed to be used through a nasal inhaler much like Narcan, the triptans and other agents. The intranasal route works rapidly and avoids first-pass hepatic metabolism. Recent PK/PD data in normal subjects has shown equivalent pharmacodynamics (urine and sodium output) when compared to IV and oral dosing. Studies now pending to see if intranasal bumetanide will help overcome diuretic resistance in our congested HF patients and keep them out of the hospital. #intranasalbumetanide #decongestathome Corstasis Therapeutics

This is why we are working hard to improve quality of life and health outcomes for ALL #heartfailure patients. Heart failure patients do not get the care they need because of: 1. Clinical inertia 2. Lack of access 3. Underappreciation of risk ….just to name a few. Join us in creating the #moonshot for heart failure. Dan Bensimhon Greg Egnaczyk Anita Kelkar MD, MPH Rebecca Steele, MSN, RN, CNL Sean O'Donnell Jason Kemmer Tara Beaird, RN, CHFN Emily Friesen Nissa Felton BSN, RN, PCCN, CHFN Omar Mousa TCTMD

No surprise here… HF comes with major costs to our patients AND our health system. Just imagine how much better it could be if we gave ALL of our patients access to the basic therapies that have been PROVEN to improve patient outcomes and reduce cost. The answer to much of this problem is sitting in plain sight….systems of care that promote rapid and widespread use of guideline-directed medical therapy. #GDMTworks #HFequity #ventriclehealth Sean O'Donnell Anita Kelkar MD, MPH Greg Egnaczyk Jason Kemmer

Underutilization of GDMT is a global health crisis. We need to breakdown traditional barriers to make sure all patients have access to lifesaving GDMT in a rapid fashion. As physicians, we need to take the lead in referring patients to HF clinics, pharmacy programs and industry partners that are specifically designed to facilitate GDMT titration. Being territorial with our patients is a legacy way of practicing medicine and leads to shorter lives, more symptoms and higher costs. #GDMTpartnerships #HFoutcomes #ventriclehealth Anita Kelkar MD, MPH Greg Egnaczyk Marat Fudim Georges Chahoud, MD, FACC, FAHA, FHFSA, FASE Sean O'Donnell Jason Kemmer Eric Prince

🔥🔥🔥🔥🔥 Ventricle Health’s ELEVATE-HF enrolls first patient today at Duke Regional Hospital. The RCT - being coordinated by the Duke Heart Center investigates the role of Ventricle Health’s virtual cardiology program in delivering expert HF care to patients recently hospitalized with HF – both reduced and preserved EF. We believe rapid titration of GDMT, patient education, and access to HF nurses and cardiologists for acute issues promises to ELEVATE the care HF patients. Adam DeVore Marat Fudim Dan Bensimhon Greg Egnaczyk Anita Kelkar MD, MPH Rebecca Steele, MSN, RN, CNL Sean O'Donnell Jason Kemmer https://lnkd.in/dQdhFxzj

Sobering facts from #HFSA. HF in younger patients is increasing, acceleration in HF mortality and worsening racial disparities in HF. Looking forward to understanding more at #HFSA2024 Annual Scientific Meeting. #heartfailure https://lnkd.in/gf2Ghk4C

The new 2024 HFSA #HFStats report also points out flaws in the timely implementation of #GDMT and structural barriers to implementation and access to care that are widening the inequity gap. What do you think? Read the report and weigh in https://lnkd.in/gxcCyzZt Journal of Cardiac Failure Biykem Bozkurt